Kineta Invited to Participate at the Oppenheimer Summit for Emerging Life Sciences Conference Seattle, WA -- (May 28, 2019) Kineta, Inc., a clinical stage biotechnology company focused on the develop ...

Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies Kineta Immuno-Oncology to receive $15 million upfront and will be eligible to receive up t ...